首页> 美国卫生研究院文献>other >Safety issues related to the electronic cross-matching of blood in mainland China
【2h】

Safety issues related to the electronic cross-matching of blood in mainland China

机译:与中国大陆血液电子交叉匹配有关的安全问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the electronic cross-matching of blood has been widely applied in some developed countries and regions, concern over the risk of undetected red blood cell (RBC) antibodies has limited its application in mainland China.This study was performed to explore the missed detection rate of RBC antibodies in a Chinese population from 2011 to 2016. If the results of 2 consecutive tests of ABO/RhD blood group identification were consistent and antibody screening results were negative, electronic cross-matching of the blood was performed. In addition, traditional serological cross-matching of blood (polybrene method) and a parallel experiment for electronic cross-matching of blood were performed to analyze the missed detection of unexpected RBC antibodies in blood donors and recipients.Using the polybrene method, 40,228 blood samples were tested by parallel traditional serological cross-matching of blood; among these samples, blood compatibility was found in 40,222 cases, primary incompatibility (incompatibility of the donor's erythrocytes with the recipient's serum) was found in 6 cases, and no secondary incompatibility was found. Identification of antibody specificity was performed using panel cells, and all unexpected RBC antibodies were confirmed as anti-Mur alloantibodies in the MNS system.Further improvements in the erythrocyte antigenic spectrum, especially the Mur antigen in Asian populations, are expected to ensure the safety of implementing electronic cross-matching in China.
机译:尽管血液的电子交叉匹配已在一些发达国家和地区得到广泛应用,但由于对未检测到的红细胞(RBC)抗体的风险的担忧限制了其在中国大陆的应用。在2011年至2016年间对中国人群的RBC抗体进行了检测。如果连续2次ABO / RhD血型鉴定的结果一致且抗体筛查结果为阴性,则对血液进行电子交叉匹配。此外,还进行了传统的血液血清学交叉匹配(聚乙烯法)和血液电子交叉匹配的平行实验,以分析漏血情况下献血者和受者中意外的RBC抗体的漏检情况。通过平行的传统血清学交叉匹配血液测试;在这些样品中,发现血液相容性40222例,发现原发性不相容性(供体的红细胞与受体的血清不相容)6例,未发现继发性不相容性。抗体特异性的鉴定是通过面板细胞进行的,所有意外的RBC抗体均被确认为MNS系统中的抗Mur异源抗体。红细胞抗原谱的进一步改善,尤其是亚洲人群的Mur抗原,有望确保其安全性。在中国实施电子交叉匹配。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号